ALSO NOTED: Iowa AG sues 78 drug makers; Jurors deliberate in Prempro trial;

> The Iowa attorney general has sued 78 pharmaceutical companies, alleging that they inflated their prices for Medicaid patients, costing the state millions over several years. With this effort, Iowa joins more than 20 states who have sued drug makers over alleged overpayments. Report

> Jurors are deliberating in Reno, Nevada, today in product liability trial over the Wyeth Pharmaceuticals drugs Premarin and Prempro. Three women with breast cancer allege that the hormone replacements caused their disease. Report

> A Johnson & Johnson unit has filed a patent-infringement suit against Hologic Inc. At issue are four patents on a  breast tumor-detection system. Report

> Merck KgaA has named a new manager for its liquid crystals division, Walter Galinat. Galinat, who had run the company's performance and life science chemicals unit, will replace Dr. Paul Breddels. Report

> China's willingness to get aggressive in protecting biopharma's intellectual property is being credited with its surge past India in the total number of completed and ongoing clinical trials. Report

> Canada's QLT has snapped up new drug delivery technology for eye conditions with its $42 million acquisition of ForSight Newco II. Report

And Finally... A recent conference in Philadelphia included some bold projections for biotech as the industry approaches the $100 billion mark for collective revenue. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.